As major pharma companies position themselves to market drugs in years to come, they’re seeing fewer blockbuster therapies on the horizon. The future lies in following the development model used by biotech companies to advance new medicines designed to target smaller populations with much more effective therapies.
John Carroll
Personalized Medicine: From Concept to Reality, Nov edition
2008 – Fierce Biotech
All our resources
blog
In our previous posts, we explored software tools used in digital health and set the foundations around potential applications of…
blog
Previously, we talked about how the EU regulates Software as Medical Device (SaMD), including AI-based software. Given that UK is…
blog
Previously, we talked about how the FDA regulates Software as Medical Device (SaMD), in this blog post we will discuss…
webinar
Software as a medical device (SaMD) has been used in the healthcare sector for many years, particularly in the space…
